» Articles » PMID: 35665984

The Performance of Five Models Compared with Atrial High Rate Episodes Predicts New Atrial Fibrillation After Cardiac Implantable Electronic Devices Implantation

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Several predicting models have been evaluated for new-onset atrial fibrillation (AF) in several clinical conditions, but never in patients with cardiac implantable electronic devices (CIED). We aimed to evaluate the five predicting models compared with atrial high rate episodes (AHRE) to predict new AF in patients with CIED.

Methods And Results: We retrospective enrolled 470 consecutive patients with CIED and without a history of AF. The five predicting models, including CHA DS -VASc score, C HEST score, mCHEST score, HAT CH score, and HAVOC score were used. The primary endpoint was new AF documented by 12-lead electrocardiography (ECG) or 30-s ECG strip. Multivariable Cox regression analysis was used to determine variables associated with independent factors of new AF. Patients' median age was 76 years and 58.7% were male. During follow-up (median 29 months), 34 new AF occurred (incidence rate 2.99/100 patient-years, 95% CI 1.67-6.20). Multivariable Cox regression analysis showed AHRE ≥6 min and 24 h, and HAT CH score were independent predictors for new AF. Optimal AHRE cutoff value was 9.3 min with highest Youden index (AUC, 0.806; 95% CI, 0.722-0.889; p < .001). The AF occurrence rate of AHRE ≥9.3 min was 7 times AHRE <9.3 min (p < .001).

Conclusions: We compared 5 predicting models for new AF in patients with CIED and without a history of AF. AHRE ≥6 min and 24 h, and HAT CH score were independent predictors for AF.

Citing Articles

The performance of five models compared with atrial high rate episodes predicts new atrial fibrillation after cardiac implantable electronic devices implantation.

Chen J, Chen T, Lu W Ann Noninvasive Electrocardiol. 2022; 27(5):e12978.

PMID: 35665984 PMC: 9484023. DOI: 10.1111/anec.12978.

References
1.
Kirchhof P, Blank B, Calvert M, Camm A, Chlouverakis G, Diener H . Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J. 2017; 190:12-18. PMC: 5546174. DOI: 10.1016/j.ahj.2017.04.015. View

2.
Doundoulakis I, Gavriilaki M, Tsiachris D, Arsenos P, Antoniou C, Dimou S . Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovasc Drugs Ther. 2021; 36(5):951-958. DOI: 10.1007/s10557-021-07209-8. View

3.
Lip G, Skjoth F, Nielsen P, Larsen T . Evaluation of the CHEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study). Am J Cardiol. 2019; 125(1):48-54. DOI: 10.1016/j.amjcard.2019.09.034. View

4.
Emren V, Aldemir M, Duygu H, Kocabas U, Tecer E, Cerit L . Usefulness of HATCH score as a predictor of atrial fibrillation after coronary artery bypass graft. Kardiol Pol. 2016; 74(8):749-753. DOI: 10.5603/KP.a2016.0045. View

5.
Zhao S, Ziegler P, Crawford M, Kwong C, Koehler J, Passman R . Evaluation of a clinical score for predicting atrial fibrillation in cryptogenic stroke patients with insertable cardiac monitors: results from the CRYSTAL AF study. Ther Adv Neurol Disord. 2019; 12:1756286419842698. PMC: 6460885. DOI: 10.1177/1756286419842698. View